Advancing Tomorrow's Medicines - Overcoming the Manufacturing Challenges Today by Steve Bagshaw, CEng, FIChemE, Chief Operating Officer, Fujifilm Diosynth Biotechnologies
Innovation in Transformative Medicine: What’s Changing the Bioprocessing Landscape by Eric Langer, President & Managing Partner, BioPlan Associates, Inc.
mRNA Medicines – Industrializing a New Platform by Juan Andres, Chief Technical Operations and Quality Officer, Moderna, Inc.
The day continued with the Exhibit Hall opening where attendees were able to take advantage of connecting with companies showcasing the latest in technology relevant to the biopharmaceutical manufacturing industry.
Follow the hashtag #ISPEBio on LinkedIn and Twitter to stay up to date on what is going on throughout the conference.
ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...